Background: Isotopic glomerular filtration rate (iGFR) measurement is comparable to the inulin method. In this study, we compared urinary and plasma iGFR methodologies in patients with diabetic nephropathy. Methods: A total of 147 patients from 3 sites in the Diabetic Intervention with Vitamins to Improve Nephropathy (DIVINe) trial provided 213 sets of urine and blood collections, at baseline, 18 and 36 months. Results: The mean (with standard deviation) plasma iGFR of 60.7 (24.9) ml/min/1.73 m2 compared to urinary iGFR of 52.0 (28.0) ml/min/1.73 m2 was statistically significant (p value <0.001). Although plasma and urinary iGFRs were highly related (R2 = 0.86), plasma iGFR increasingly overestimated urinary iGFRs at lower GFRs. In contrast to the cross-sectional analyses, the two measures of iGFR were weakly related (R2 = 0.32) in regard to patients' change over 18 months of follow-up. Conclusion: Plasma iGFR may not be a suitable method for accurately measuring GFR in patients with advancing degrees of chronic kidney disease from diabetic nephropathy.

Keywords:
Chronic renal disease, Glomerular filtration rate, Isotopic glomerular filtration rate, Plasma clearance method, Urinary clearance method, Technetium-99m-diethylenetriamine pentaacetic acid
1.
Poggio ED, Nef PC, Wang X, et al: Performance of the Cockcroft-Gault and modification of diet in renal disease equations in estimating GFR in ill hospitalized patients. Am J Kidney Dis 2005;46:242-252.
2.
Stevens LA, Coresh J, Feldman HI, et al: Evaluation of the modification of diet in renal disease study equation in a large diverse population. J Am Soc Nephrol 2007;18:2749-2757.
3.
Shannon JA, Smith HW: The excretion of inulin, xylose and urea by normal and phlorizinized man. J Clin Invest 1935;14:393-401.
4.
Fleming JS, Zivanovic MA, Blake GM, Burniston M, Cosgriff PS: Guidelines for the measurement of glomerular filtration rate using plasma sampling. Nucl Med Commun 2004;25:759-769.
5.
Cherney DZ, Lai V, Scholey JW, Miller JA, Zinman B, Reich HN: Effect of direct renin inhibition on renal hemodynamic function, arterial stiffness, and endothelial function in humans with uncomplicated type 1 diabetes: a pilot study. Diabetes Care 2010;33:361-365.
6.
Morton KA, Pisani DE, Whiting JH Jr, Cheung AK, Arias JM, Valdivia S: Determination of glomerular filtration rate using technetium-99m-DTPA with differing degrees of renal function. J Nucl Med Technol 1997;25:110-114.
7.
Rehling M, Moller ML, Thamdrup B, Lund JO, Trap-Jensen J: Simultaneous measurement of renal clearance and plasma clearance of 99mTc-labelled diethylenetriaminepenta-acetate, 51Cr-labelled ethylenediaminetetra-acetate and inulin in man. Clin Sci (Lond) 1984;66:613-619.
8.
Picciotto G, Cacace G, Cesana P, Mosso R, Ropolo R, De Filippi PG: Estimation of chromium-51 ethylene diamine tetra-acetic acid plasma clearance: a comparative assessment of simplified techniques. Eur J Nucl Med 1992;19:30-35.
9.
Biggi A, Viglietti A, Farinelli MC, Bonada C, Camuzzini G: Estimation of glomerular filtration rate using chromium-51 ethylene diamine tetra-acetic acid and technetium-99m diethylene triamine penta-acetic acid. Eur J Nucl Med 1995;22:532-536.
10.
Fleming JS, Wilkinson J, Oliver RM, Ackery DM, Blake GM, Waller DG: Comparison of radionuclide estimation of glomerular filtration rate using technetium-99m diethylenetriaminepentaacetic acid and chromium-51 ethylenediaminetetraacetic acid. Eur J Nucl Med 1991;18:391-395.
11.
Fotopoulos A, Bokharhli JA, Tsiouris S, et al: Comparison of six radionuclidic and non-radionuclidic methods for the assessment of glomerular filtration rate in patients with chronic renal failure. Hell J Nucl Med 2006;9:133-140.
12.
Itoh K: Comparison of methods for determination of glomerular filtration rate: Tc-99m-DTPA renography, predicted creatinine clearance method and plasma sample method. Ann Nucl Med 2003;17:561-565.
13.
LaFrance ND, Drew HH, Walser M: Radioisotopic measurement of glomerular filtration rate in severe chronic renal failure. J Nucl Med 1988;29:1927-1930.
14.
Levey AS, Coresh J, Greene T, et al: Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate. Ann Intern Med 2006;145:247-254.
15.
House AA, Eliasziw M, Cattran DC, et al: Effect of B-vitamin therapy on progression of diabetic nephropathy: a randomized controlled trial. JAMA 2010;303:1603-1609.
16.
Shemesh O, Golbetz H, Kriss JP, Myers BD: Limitations of creatinine as a filtration marker in glomerulopathic patients. Kidney Int 1985;28:830-838.
17.
DuBois D, DuBois EF: A formula to estimate the approximate surface area if height and weight be known. Arch Intern Med 1916;17:863-871.
18.
Russell CD, Bischoff PG, Kontzon FN, Rowell KL, Yester MV, Lloyd LK, et al: Measurement of glomerular filtration rate: single injection plasma clearance method without urine collection. J Nucl Med 1985;26:1243-1247.
19.
Blaufox MD, Aurell M, Bubeck B, et al: Report of the Radionuclides in Nephrourology Committee on renal clearance. J Nucl Med 1996;37:1883-1890.
20.
Waller DG, Keast CM, Fleming JS, Ackery DM: Measurement of glomerular filtration rate with technetium-99m DTPA: comparison of plasma clearance techniques. J Nucl Med 1987;28:372-377.
21.
Fleming JS, Persaud L, Zivanovic MA: Quality control of slope-intercept measurements of glomerular filtration rate using single-sample estimates. Nucl Med Commun 2005;26:737-742.
22.
Chantler C, Barratt TM: Estimation of glomerular filtration rate from plasma clearance of 51-chromium edetic acid. Arch Dis Child 1972;47:613-617.
23.
Filler G, Priem F, Lepage N, et al: Beta-trace protein, cystatin C, beta(2)-microglobulin, and creatinine compared for detecting impaired glomerular filtration rates in children. Clin Chem 2002;48:729-736.
24.
Chantler C, Garnett ES, Parsons V, Veall N: Glomerular filtration rate measurement in man by the single injection methods using 51Cr-EDTA. Clin Sci 1969;37:169-180.
25.
Brochner-Mortensen J: A simple method for the determination of glomerular filtration rate. Scand J Clin Lab Invest 1972;30:271-274.
© 2015 S. Karger AG, Basel
2015
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.